Pyrimidine compounds as mTOR and PI3K inhibitors
US9801888B2 · kind B2 · utility
0Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 21, 2016 |
| Grant date | Oct 31, 2017 |
| Priority date | — |
| Expiry date | Jan 21, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pyrimidine compounds of formula (I):which are useful in treating mTOR kinase- or PI3K kinase-related diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.